From an analysis of calculated physicochemical properties for 81 currently marketed respiratory drugs, compounds administered via the inhaled/intranasal routes have a higher polar surface area, a higher molecular weight, and a trend toward lower lipophilicity, when compared with their orally administered counterparts. Ranges of physicochemical space are described for the 29 drugs administered by the inhaled or intranasal routes.
No takes yet. Share an insight, caveat, or question.
Ritchie et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: